by Georgina Matthews | Oct 27, 2025 | News
Exogene, a techbio start-up developing T-cell receptor (TCR)-based therapies for the treatment of cancer, has taken 797 sq ft (74 sq m) R&D laboratory space and co-working in Barclays Eagle Labs at our Wood Centre for Innovation in Headington. Co-founded by...
